Evaluation/titration of RBV stock/VLP manufacture
Ended Purchase Order Awarded Last action
- Contract number
- 75N93019P00872
- Awardee
-
Medigen, Inc. UEI MGLJHKGKWBL3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,640
Award facts
- Contract value 100% obligated
- $15,640.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Medigen, Inc. on July 29, 2019, for evaluation and titration of RBV stock and VLP manufacture, with a firm fixed price ceiling of $15,640.00 and ultimate completion by September 3, 2019. The order carries a total small business set-aside. Work is performed in Frederick, Maryland.
Quick answers
Who was awarded contract 75N93019P00872?
75N93019P00872 was awarded to Medigen, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 29, 2019.
How much is contract 75N93019P00872 worth?
The government has obligated $15,640 on 75N93019P00872.
Was contract 75N93019P00872 competed?
The extent of competition for 75N93019P00872 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award